HEALTHTHE GUARDIAN TECH
Final frontier for meds? UK startup sends drug-making into space
A UK startup, BioOrbit, launched a drug-crystallisation technology unit called Box-E to the International Space Station via SpaceX to grow ultra-pure protein crystals. The goal is to develop self-injected cancer treatments that could save millions of lives.
Mentioned
Related Signal
Adjacent reporting
- Could this be the moment that drug manufacturing takes off in orbit?
- Google AI legend raises big money for startup targeting this cutting-edge goal
- AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration